1-3 of 3
Dirk Daelemans
Close
Sort by
Journal Articles

CRISPR/Cas9 Chemogenetic Profiling Identifies Candidate Biomarker Genes That Modulate Sensitivity to Selinexor

Bert Kwanten, MSc, Yosef Landesman, PhD, Dirk Daelemans
Journal: Blood
Blood (2020) 136 (Supplement 1): 14.
https://doi.org/10.1182/blood-2020-141785
Published: 2020
Journal Articles

Selective Inhibitors of Nuclear Export (SINE) Compounds Suppress Both HIV Replication and AIDS Related Lymphoma

Dirk Daelemans, PhD, Eline Boons, Els Vanstreels, Maarten Jacquemyn, Tatiane C Nogueira, Jasper E Neggers, Thomas Vercruysse, Joost van den Oord, Sharon Tamir, Michael Kauffman, MD PhD, Sharon Shacham, Yosef Landesman, PhD, Robert Snoeck, Christophe Pannecouque, Graciela Andrei
Journal: Blood
Blood (2015) 126 (23): 2751.
https://doi.org/10.1182/blood.V126.23.2751.2751
Published: 2015
Journal Articles

Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia

Rosa Lapalombella, Qingxiang Sun, Katie Williams, Larissa Tangeman, Shruti Jha, Yiming Zhong, Virginia Goettl, Emilia Mahoney, Caroline Berglund, Sneha Gupta, Alicia Farmer, Rajeswaran Mani, Amy J. Johnson, David Lucas, Xiaokui Mo, Dirk Daelemans, Vincent Sandanayaka, Sharon Shechter, Dilara McCauley, Sharon Shacham, Michael Kauffman, Yuh Min Chook, John C. Byrd
Journal: Blood
Blood (2012) 120 (23): 4621–4634.
https://doi.org/10.1182/blood-2012-05-429506
Published: 2012
Includes: Supplemental data